Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

OncoSpark And ELLKAY Announce New Partnership To Use Interoperability To Solve Prior Authorization Challenges In Oncology

OncoSpark, Inc. a leader in value-based care driven by data from technology enabled services, and ELLKAY, LLC, a leader in healthcare interoperability for over 19 years, have joined forces to solve the challenge of prior authorization in the oncology space. OncoSpark’s platform, AuthParency, is the only solution dedicated to accomplishing this. The platform was built with a tailored approach to interoperability through ELLKAY.

OncoSpark’s team worked in tandem with the interoperability architects at ELLKAY to ensure the solution met the challenges presented by oncology: clinical variables, pathways, exceptions, and health policy considerations. What came of the collaboration was a solution that ensures prior authorization in oncology practices through seamless connectivity providing the data needed for providers and staff to focus on the patient and gives patients confidence and clarity in knowing how they are covered for their care as well as mitigating delays this current process creates.

Recommended AI News: Avantive Solutions Expands Global Offerings

Jordan Johnson, Chief Innovation Officer of OncoSpark said, “Prior Authorization remains the largest problem for cancer patients, and current oncology practices utilize numerous systems with disparate data that is neither relational nor valuable when unstructured/siloed. With ELLKAY and AuthParency, we have created cross cutting subject matter expertise of the process by integrating over 200 discrete data points that connect practice to payer to pharma.”

Related Posts
1 of 40,471

Prior authorization has long created unnecessary financial burdens and challenges for hospitals, providers, and patients. The AuthParency platform mitigates financial toxicity and delays through promotion of unparalleled transparency for patients, payers, pharma, and providers.

Recommended AI News: HiDubai Introduces a New AI-Powered Deal Discovery Feature to Help Tourists and Residents Do Smart Shopping

Gurpreet Singh, ELLKAY’s Vice President of Interoperability Solutions, said, “We loved working with the OncoSpark team to ensure oncology patients have clarity in the coverage of their care. Our interoperability experts are happy to handle the back-end connectivity for our partners so they can focus their resources on their core business. OncoSpark’s passion for ensuring a seamless workflow for their oncology partners drove the ELLKAY team to ensure we tailored the interoperability connectivity to do its part.”

Johnson added, “ELLKAY’s commitment to effective interoperability and unparalleled understanding of all aspects of healthcare barriers, opportunities, and proven results made them the clear partner for OncoSpark and their mission. We already have interest and are working with ELLKAY to expand beyond the oncology service line.”

Recommended AI News: EdgeCortix Acquires Multiple Patents for Dynamic Neural Accelerator AI Processor Technology

[To share your insights with us, please write to sghosh@martechseries.com]

Comments are closed.